Showing results (21-30 of 1,477) with videos related to
Sort By:
Pageof 148
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsetsJ A Smith, Q Tang, J A BluestonePrincess Takamatsu Symposia|January 1, 1988
In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growthR Hirsch, J D Ellenhorn, J A BluestoneTransplantation|March 15, 1996
In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cellsE S Woodle, S Hussein, J A BluestoneNature|November 19, 1987
Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytesL A Matis, R Cron, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated miceJ D Ellenhorn, H Schreiber, J A BluestoneThe Journal of Experimental Medicine|April 1, 1983
Antiidiotypes against anti-H-2 monoclonal antibodies. V. In vivo antiidiotype treatment induces idiotype-specific helper T cellsH Auchincloss, J A Bluestone, D H SachsThe Journal of Experimental Medicine|August 1, 1985
Evidence for a regulatory idiotypic network in the in vivo response to H-2 antigensR Rabinowitz, J A Bluestone, D H SachsThe Journal of Experimental Medicine|June 1, 1993
Tolerance of T cell receptor gamma/delta cells in the intestineT A Barrett, Y Tatsumi, J A BluestoneAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsS M Kang, Q Tang, J A BluestoneThe Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J MadrenasPageof 148